Genetic susceptibility to raised dermal scarring

British Journal of Dermatology

Volumn 161, Issue 1, 2009, Pages 8-18

  Brown, J J ^a   Bayat, A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Familial tendency; Genetic predisposition; Heritability; Hypertrophic scarring; Keloid disease

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALLELE; CASE CONTROL STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEREDITY; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC SCAR; IMMUNOGENETICS; IMMUNOPHENOTYPING; KELOID; LINKAGE ANALYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RAISED SKIN SCAR; REVIEW; SKIN FIBROSIS; SKIN SCAR; SYSTEMATIC REVIEW; WOUND HEALING IMPAIRMENT;

CICATRIX, HYPERTROPHIC; GENETIC PREDISPOSITION TO DISEASE; HLA-D ANTIGENS; HUMANS; KELOID; LINKAGE (GENETICS);

EID: 67649933647     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09258.x     Document Type: Review

References (57)

1. Bayat A, McGrouther DA. Clinical management of skin scarring. Skinmed 2005 4 : 165 73.
2. Grose R, Werner S. Wound-healing studies in transgenic and knockout mice. Mol Biotechnol 2004 28 : 147 66.
3. Gurtner GC, Werner S, Barrandon Y et al. Wound repair and regeneration. Nature 2008 453 : 314 21.
4. Bayat A, Arscott G, Ollier WE et al. 'Aggressive keloid': a severe variant of familial keloid scarring. J R Soc Med 2003 96 : 554 5.
5. Bayat A, Arscott G, Ollier WE et al. Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg 2005 58 : 28 37. (Pubitemid 40089678)
6. Bayat A, McGrouther DA. Spectrum of abnormal skin scars and their clinical management. Br J Hosp Med (Lond) 2006 67 : 527 32.
7. Durani P, Bayat A. Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg 2008 61 : 4 17. (Pubitemid 350199116)
8. Armour A, Scott PG, Tredget EE. Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen 2007 15 (Suppl. 1 S6 17.
9. Berman B, Viera MH, Amini S et al. Prevention and management of hypertrophic scars and keloids after burns in children. J Craniofac Surg 2008 19 : 989 1006.
10. Kose O, Waseem A. Keloids and hypertrophic scars: are they two different sides of the same coin? Dermatol Surg 2008 34 : 336 46.
11. Bayat A, Watson JS, Stanley JK et al. Novel single nucleotide polymorphisms in the 3′-UTR of the TGFbetaRI and TGFbetaRIII genes. Eur J Immunogenet 2002 29 : 445 6.
12. Omo-Dare P. Genetic studies on keloid. J Natl Med Assoc 1975 67 : 428 32.
13. Marneros AG, Norris JE, Olsen BR et al. Clinical genetics of familial keloids. Arch Dermatol 2001 137 : 1429 34.
14. Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990 43 : 70 7.
15. Kurwa AR. Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol 1979 4 : 251 4.
16. Goodfellow A, Emmerson RW, Calvert HT. Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol 1980 5 : 369 70.
17. Selmanowitz VJ, Stiller MJ. Rubinstein-Taybi syndrome. Cutaneous manifestations and colossal keloids. Arch Dermatol 1981 117 : 504 6.
18. Partington MW. Rubinstein-Taybi syndrome: a follow-up study. Am J Med Genet Suppl 1990 6 : 65 8.
19. Hendrix JD Jr., Greer KE. Rubinstein-Taybi syndrome with multiple flamboyant keloids. Cutis 1996 57 : 346 8.
20. Goeminne L. A new probably X-linked inherited syndrome: congenital muscular torticollis, multiple keloids cryptorchidism and renal dysplasia. Acta Genet Med Gemellol (Roma) 1968 17 : 439 67.
21. Burk CJ, Aber C, Connelly EA. Ehlers-Danlos syndrome type IV: keloidal plaques of the lower extremities, amniotic band limb deformity, and a new mutation. J Am Acad Dermatol 2007 56 : S53 4.
22. Zuffardi O, Fraccaro M. Gene mapping and serendipity. The locus for torticollis, keloids, cryptorchidism and renal dysplasia (31430, McKusick) is at Xq28, distal to the G6PD locus. Hum Genet 1982 62 : 280 1.
23. Marneros AG, Norris JE, Watanabe S et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 2004 122 : 1126 32.
24. Chen Y, Gao JH, Liu XJ et al. [Linkage analysis of keloid susceptibility loci on chromosome 7p11 in a Chinese pedigree]. Nan Fang Yi Ke Da Xue Xue Bao 2006 26 : 623 5 [in Chinese].
25. Yan X, Gao JH, Chen Y et al. [Preliminary linkage analysis and mapping of keloid susceptibility locus in a Chinese pedigree]. Zhonghua Zheng Xing Wai Ke Za Zhi 2007 23 : 32 5 [in Chinese].
26. Satish L, Babu M, Tran KT et al. Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways. Wound Repair Regen 2004 12 : 183 92.
27. Yu H, Bock O, Bayat A et al. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. J Plast Reconstr Aesthet Surg 2006 59 : 221 9.
28. Satish L, Lyons-Weiler J, Hebda PA et al. Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen 2006 14 : 463 70.
29. Chen W, Fu XB, Ge SL et al. Development of gene microarray in screening differently expressed genes in keloid and normal-control skin. Chin Med J (Engl) 2004 117 : 877 81.
30. Dasu MR, Hawkins HK, Barrow RE et al. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J Pathol 2004 202 : 476 85.
31. Na GY, Seo SK, Lee SJ et al. Upregulation of the NNP-1 (novel nuclear protein-1, D21S2056E) gene in keloid tissue determined by cDNA microarray and in situ hybridization. Br J Dermatol 2004 151 : 1143 9.
32. Naitoh M, Kubota H, Ikeda M et al. Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage. Genes Cells 2005 10 : 1081 91.
33. Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol 2006 195 : 415 20.
34. Hu ZF, Gao JH, Li W et al. [Differential gene expression profile of keloids: a study with cDNA microarray]. Nan Fang Yi Ke Da Xue Xue Bao 2006 26 : 308 12 [in Chinese].
35. Ghazizadeh M, Tosa M, Shimizu H et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol 2007 127 : 98 105. (Pubitemid 46005666)
36. Xia W, Kong W, Wang Z et al. Increased CCN2 transcription in keloid fibroblasts requires cooperativity between AP-1 and SMAD binding sites. Ann Surg 2007 246 : 886 95.
37. Luo X, Pan Q, Liu L et al. Genomic and proteomic profiling II: comparative assessment of gene expression profiles in leiomyomas, keloids, and surgically induced scars. Reprod Biol Endocrinol 2007 5 : 35.
38. Chu Y, Guo F, Li Y et al. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts. Connect Tissue Res 2008 49 : 92 8.
39. Sadick H, Herberger A, Riedel K et al. TGF-beta1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts. Int J Mol Med 2008 22 : 55 60.
40. Smith JC, Boone BE, Opalenik SR et al. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 2008 128 : 1298 310.
41. Seifert O, Bayat A, Geffers R et al. Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen 2008 16 : 254 65.
42. Lu F, Gao J, Ogawa R et al. Biological differences between fibroblasts derived from peripheral and central areas of keloid tissues. Plast Reconstr Surg 2007 120 : 625 30.
43. Nassiri M, Woolery-Lloyd H, Ramos S et al. Gene expression profiling reveals alteration of caspase 6 and 14 transcripts in normal skin of keloid-prone patients. Arch Dermatol Res 2008 301 : 183 8.
44. Bayat A, Bock O, Mrowietz U et al. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003 111 : 535 43.
45. Jagadeesan J, Bayat A. Transforming growth factor beta (TGFbeta) and keloid disease. Int J Surg 2007 5 : 278 85.
46. Bayat A, Bock O, Mrowietz U et al. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg 2002 55 : 283 6.
47. Bayat A, Walter JM, Bock O et al. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 gene. Br J Plast Surg 2005 58 : 914 21.
48. Bayat A, Bock O, Mrowietz U et al. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 2004 13 : 120 4.
49. Brown JJ, Ollier W, Arscott G et al. Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. Exp Dermatol 2008 17 : 610 13.
50. Brown JJ, Ollier WE, Thomson W et al. Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int J Immunogenet 2008 35 : 303 7.
51. Lu WS, Wang JF, Yang S et al. Association of HLA-DQA1 and DQB1 alleles with keloids in Chinese Hans. J Dermatol Sci 2008 52 : 108 17.
52. Zhang F, Laiho M. On and off: proteasome and TGF-beta signaling. Exp Cell Res 2003 291 : 275 81.
53. Wang Z, Gao Z, Shi Y et al. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg 2007 60 : 1193 9.
54. Chin D, Boyle GM, Theile DR et al. The human genome and gene expression profiling. J Plast Reconstr Aesthet Surg 2006 59 : 902 11.
55. Santucci M, Borgognoni L, Reali UM et al. Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles. Virchows Arch 2001 438 : 457 63.
56. Al-Attar A, Mess S, Thomassen JM et al. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006 117 : 286 300. (Pubitemid 44391579)
57. Robles DT, Moore E, Draznin M et al. Keloids: pathophysiology and management. Dermatol Online J 2007 13 : 9.